Biomaterials in droplet-based microfluidics: From structural design to biomedical applications

Droplet-based microfluidics (DBM) affords reproducible control over the breakup of immiscible streams, enabling the on-demand fabrication of well-defined carriers for biomedical use. We first outline droplet-generation techniques, distinguishing passive architectures—in which capillary, viscous, and inertial forces set size and frequency—from active methods that superimpose external fields to refine monodispersity, throughput, and size control. Building on this physical framework, we survey the micro- and nanostructures accessible with DBM—including polymeric nanoparticles and nanogels/microgels, microspheres, core–shell microcapsules, and microfibers—and show how morphology (porosity, shell thickness, network architecture) and spatial composition govern transport, stability, and release. We then examine the biomaterials that endow droplets with function, with emphasis on natural, semi-synthetic, and synthetic hydrogels and on gelation/polymerization routes (ionic, thermal, photo-induced, enzymatic) that are compatible with biological cargo and permit real-time structural control. The applications analysis is intentionally biomaterial-centric. For drug delivery, we relate material choice and crosslinking chemistry to representative release profiles and kinetic models, and we integrate quantitative biocompatibility readouts where available (e.g., LD50, inflammatory signaling) together with in vivo biodistribution and loading efficiency that link carrier design to payload fate. For cell-centric uses, we discuss single-cell encapsulation and droplet-based 3D cultures, highlighting biomaterial-driven morphogenesis, viability, and function, and we outline DBM-enabled bioanalytical platforms (single-molecule detection, single-cell sequencing). By articulating the pathway from droplet-generation techniques, through the resulting micro-/nanostructures and the selected biomaterials, to their biomedical performance, this review provides a coherent design perspective for engineering DBM-fabricated carriers and scaffolds in drug delivery, tissue modeling, and high-throughput bioanalysis.

Authors

Publication Details

Journal
Materials Today Advances
Published
2025-11-21
DOI
https://doi.org/10.1016/j.mtadv.2025.100667
Citations
1
Primary Topic
Innovative Microfluidic and Catalytic Techniques Innovation
Type
article
Field-Weighted Citation Impact
0.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biomaterials in droplet-based microfluidics: From structural design to biomedical applications

Candido Fabrizio Pirri, Matteo Cocuzza, Lucia Napione, Francesca Frascella et al.
1 citations
Materials Today Advances
Innovative Microfluidic and Catalytic Techniques Innovation
0.67
article

Biomaterials in droplet-based microfluidics: From structural design to biomedical applications

Candido Fabrizio Pirri, Matteo Cocuzza, Lucia Napione, Francesca Frascella, Simone Luigi Marasso, Cesare Gabriele Gaglio, Andrea Fergola
article en
1 citations

Abstract

Droplet-based microfluidics (DBM) affords reproducible control over the breakup of immiscible streams, enabling the on-demand fabrication of well-defined carriers for biomedical use. We first outline droplet-generation techniques, distinguishing passive architectures—in which capillary, viscous, and inertial forces set size and frequency—from active methods that superimpose external fields to refine monodispersity, throughput, and size control. Building on this physical framework, we survey the micro- and nanostructures accessible with DBM—including polymeric nanoparticles and nanogels/microgels, microspheres, core–shell microcapsules, and microfibers—and show how morphology (porosity, shell thickness, network architecture) and spatial composition govern transport, stability, and release. We then examine the biomaterials that endow droplets with function, with emphasis on natural, semi-synthetic, and synthetic hydrogels and on gelation/polymerization routes (ionic, thermal, photo-induced, enzymatic) that are compatible with biological cargo and permit real-time structural control. The applications analysis is intentionally biomaterial-centric. For drug delivery, we relate material choice and crosslinking chemistry to representative release profiles and kinetic models, and we integrate quantitative biocompatibility readouts where available (e.g., LD50, inflammatory signaling) together with in vivo biodistribution and loading efficiency that link carrier design to payload fate. For cell-centric uses, we discuss single-cell encapsulation and droplet-based 3D cultures, highlighting biomaterial-driven morphogenesis, viability, and function, and we outline DBM-enabled bioanalytical platforms (single-molecule detection, single-cell sequencing). By articulating the pathway from droplet-generation techniques, through the resulting micro-/nanostructures and the selected biomaterials, to their biomedical performance, this review provides a coherent design perspective for engineering DBM-fabricated carriers and scaffolds in drug delivery, tissue modeling, and high-throughput bioanalysis.

Materials Today AdvancesVol. 28
Openalex Percentile: Top 24%
Innovative Microfluidic and Catalytic Techniques Innovation
0.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.